Reflecting on Errors and Missed Opportunities in CLL

Title:

Reflecting on Errors and Missed Opportunities in CLL

Topic: Oncology
Relevant Terms: Chronic lymphocytic leukemia
Primary Audience: Oncology specialists, including physicians, nurse practitioners, and physician assistants
Launch Date: 11-Apr-17
Credits: AMA PRA Category 1 Credit
Expiration Date: 11-Apr-18
Curriculum Name: Reflecting on Errors and Missed Opportunities in CLL

Learning Objectives

After completing this activity, the participant will demonstrate the ability to:

  1. Implement advances in chronic lymphocytic leukemia (CLL) testing to help refine diagnosis, predict prognosis, and select the most appropriate personalized treatment approaches
  2. Utilize new and emerging targeted treatments for CLL patients based on efficacy, clinical trial data, and guidelines in order to individualize treatment regimens
  3. Integrate evidence-based strategies into the management of side effects associated with CLL treatments

    Faculty

    Ian W. Flinn, MD, PhD
    Director of Lymphoma/CLL Program
    Sarah Cannon Center for Blood Cancer
    Nashville, TN
    Richard R. Furman, MD
    The Morton Coleman, MD Distinguished Associate Professor of Medicine
      Division of Hematology and Oncology
    Weill Cornell Medical College
    New York, NY
    William G. Wierda, MD, PhD
    Distinguished Professor, D.B. Lane Cancer Research
    The University of Texas MD Anderson Cancer Center
    Houston, TX
    PHYSICIAN CONTINUING MEDICAL EDUCATION
    Accreditation Statement
    This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Albert Einstein College of Medicine and RMEI Medical Education, LLC. Albert Einstein College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

    Credit Designation
    The Albert Einstein College of Medicine designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    Financial Disclosure
    The “Conflict of Interest Disclosure Policy” of Albert Einstein College of Medicine requires that faculty participating in any CME activity disclose to the audience any relevant relationship(s) with a pharmaceutical, product, or device company. Any presenter whose disclosed relationships prove to create a conflict of interest with regard to their contribution to the activity will not be permitted to present. 
     
    Albert Einstein College of Medicine also requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. Albert Einstein College of Medicine, CCME staff, has no relevant conflicts of interest with commercial interests related directly or indirectly to this educational activity. 

    The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests, but these relationships will not affect their ability to have an unbiased contribution to the educational content of this CME activity:
     
    • Ian W. Flinn, MD, PhD, has affiliations with Acerta, BeiGene, Celgene, Genentech, Gilead, Infinity, Janssen, and TG Therapeutics (Contracted Research).
    • Richard R. Furman, MD, has affiliations with AbbVie, Genentech, Gilead, Janssen, and Pharmacyclics (Consulting Fees); and Pharmacyclics (Speakers Bureau).
    • William G. Wierda, MD, PhD, has affiliations with AbbVie, Celgene, Emergent, Genentech/Roche, Genzyme, Gilead, GlaxoSmithKline/Novartis, Merck, Pharmacyclics, and Sanofi (Consulting Fees); AbbVie, Ascerta, Emergent, Genentech, Gilead, GlaxoSmithKline/Novartis, Janssen, Juno, Karyopharm, Kite Pharma, and Pharmacyclics (Contracted Research).
    RMEI Medical Education, LLC
    • Jacqui Brooks, MBBCh, MRCPsych, has no affiliations with commercial interests to disclose.
    • Chelsey Goins, PhD, has no affiliations with commercial interests to disclose.
    • Sherri Kramer, MD, has no affiliations with commercial interests to disclose.
    • Leslie Treff, JD, has no affiliations with commercial interests to disclose.
    The following Einstein peer reviewer reported the following financial relationships or relationships to
    products or devices they or their spouse/life partner have with commercial interests related to the
    content of this CME activity:
     
    • Amit K. Verma, MD, has no affiliations with commercial interests to disclose.
    DISCLAIMER
    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients' conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.
     
    DISCLOSURE OF UNLABELED USE
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Albert Einstein College of Medicine, Montefiore Medical Center, RMEI Medical Education, LLC, or AbbVie. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
     
    Estimated time to complete: 1.0 hours
    Medium: Internet
     
    FEE INFORMATION
    There is no fee for this educational activity.

    COMMERCIAL SUPPORT
    This activity is supported by an independent educational grant from AbbVie.

    HOW TO RECEIVE CREDIT
    By reviewing the course content and successfully completing the post-test and evaluation, physicians, nurse practitioners, and physician assistants are entitled to receive up to 1.0 AMA PRA Category 1 Credit(s)™. A statement of credit will be available to print from your user history page. Users must:
     
    • Read the learning objectives and faculty disclosures.
    • Participate in the activity.
    • Complete the activity evaluation.
    Physicians, nurse practitioners, and physician assistants who successfully complete the post-test and evaluation will receive CME credit. You must score 75% or higher on the post-test to receive credit for this activity. All other participants who successfully complete the post-test and evaluation will receive a certificate of participation.
     
    COURSE VIEWING REQUIREMENTS
    Supported Browsers:
    Internet Explorer 9.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
    Google Chrome 28.0+ for Windows, Mac OS, or Linux
    Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
    Safari 6.0+ for Mac OSX 10.7 and above

     
    Supported Phones & Tablets:
    Android 4.0.3 and above
    iPhone/iPad with iOS 6.1 or above.